Mission & Story
Mission
Our mission is to translate the genetic language of the adaptive immune system into clinical products to diagnose and treat disease.
Founding Story
Founded on the premise that if you could read how the adaptive immune system detects and treats disease, you could harness these natural abilities to make a difference in the lives of people living with many different diseases. Co-founded by Chad Robins (CEO) and Harlan Robins, PhD (Chief Scientific Officer).
Clinical Focus
Medical conditions and clinical areas addressed by Adaptive Biotechnologies.
Who It Serves
Milestones & Awards
Recent Milestones
New data at ASCO and EHA 2026 reinforcing clonoSEQ MRD testing role. Two immune receptor licensing agreements with Pfizer announced. Earned HRC 2025 Corporate Equality Index Cornerstone Recognition. 15+ years of domain expertise milestone.
Awards & Recognition
HRC 2025 Corporate Equality Index Cornerstone Recognition for LGBTQ+ workplace inclusion. Published in world's leading peer-reviewed journals.
Key Partnerships
Social & Media
Latest Updates
Adaptive Earns Cornerstone Recognition for LGBTQ+ Workplace Inclusion in HRC’s 2025 Corporate Equality Index
Immune Medicine in Action: How Adaptive Immunosequencing Helped Validate a Personalized Vaccine Trial in PDAC
Jim’s Journey: The Power of Collaboration in Blood Cancer Care
Clinically Actionable Insights: A Q&A with Dr. Luciano Costa on the Final Analysis of MASTER
Hope restored: The critical role that Minimal Residual Disease can play in blood cancer patient care
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 60 →
23andMe
23andMe uses AI to analyze genetic data and provide personalized health summaries, risk assessments, and wellness recommendations based on genomic insights.
2bPrecise
AI-powered precision medicine platform for personalized treatment recommendations and genomic analysis.
ACT Genomics
AI-powered genomic analysis platform for precision medicine and personalized treatment recommendations.
Ambry Genetics
Ambry Genetics is a leading clinical genetic testing laboratory specializing in hereditary cancer, rare disease, cardiology, and neurology testing. The company provides advanced genetic testing solutions with paired DNA/RNA analysis and comprehensive patient support programs.
Ataraxis
Ataraxis develops AI-native precision medicine tools that predict patient outcomes and treatment response in oncology. Their flagship product, Ataraxis Breast, provides clinically validated prognostic and predictive tests for breast cancer using multi-modal AI analysis of pathology images and clinical data.
Avenda Health
Avenda Health develops Unfold AI, an FDA-cleared artificial intelligence platform that creates 3D cancer estimation maps for prostate cancer. The technology analyzes standard-of-care data (MRI, biopsy, pathology, PSA) to visualize cancer location and extent, helping physicians make more informed treatment decisions and improve patient outcomes.
Base Genomics
Base Genomics appears to be a company in the Precision Medicine & Genomics space, but the scraped website content is empty or inaccessible, preventing detailed analysis of their offerings and target market.
Beacon Biosignals
Beacon Biosignals is a precision neuroscience platform that uses AI-powered technology to accelerate drug development and power home sleep testing diagnostics. The company collects, integrates, and analyzes EEG data across the full drug development lifecycle.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.